Research Solutions Inc (RSSS)
Official siteTECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ
Market Cap: $63.81M
Last updated: Nov 17, 2026 at 4:10 PM ET
Research Solutions Inc (RSSS) Stock Chart
Research Solutions (RSSS) has a latest price of $2.12 on Nov 17, 2026, 37.3% below its 52-week high of $3.38. Its price fell 33.8% over the past 12 months. The month-end price rose 83.0% over the 10 years through Oct 2026, a compound annual rate of 6.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $4.15 in Dec 2024 and its lowest $0.95 in May 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RSSS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RSSS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.1%, and over 6 months it was flat. The month-end price fell 22.1% over the 3 years through Oct 2026, a compound annual decline of 8.0%.
| Period | Change |
|---|---|
| 1 month | +6.0% |
| 3 months | -4.1% |
| 6 months | 0.0% |
| 12 months | -33.8% |
| 12 months, with dividends | -33.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -22.1% | -8.0% |
| 5 years | -27.1% | -6.1% |
| 10 years | +83.0% | +6.2% |
Price by Year
Its best calendar year was 2018, when the price rose 100.8%, and its weakest was 2020, when it fell 35.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.83 | -37.8% |
| 2025 | $2.94 | -29.2% |
| 2024 | $4.15 | +59.6% |
| 2023 | $2.60 | +35.4% |
| 2022 | $1.92 | -22.0% |
| 2021 | $2.46 | +5.6% |
| 2020 | $2.33 | -35.3% |
| 2019 | $3.60 | +46.9% |
| 2018 | $2.45 | +100.8% |
| 2017 | $1.22 | +18.4% |
Trading Range
The price is 5.9% above its 50-day average of $2.00 and 5.8% below its 200-day average of $2.25.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.12 | |
| 52-week high | $3.38 | -37.3% |
| 52-week low | $1.77 | +19.8% |
| 50-day average | $2.00 | +5.9% |
| 200-day average | $2.25 | -5.8% |
Price Risk
Over 3 years, its largest fall from a peak was 56.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.40 |
| Largest fall, 1 year | -43.1% |
| Largest fall, 3 years | -56.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RSSS
What is RSSS's 1-year price change?
Research Solutions's price fell 33.8% over the past 12 months. With dividends included, the 12-month total return was -33.8%.
What is RSSS's 5-year price change?
Research Solutions's month-end price fell 27.1% over the 5 years through Oct 2026, a compound annual decline of 6.1%. These figures leave out dividends.
What is RSSS's 52-week high and low?
Research Solutions's 52-week high is $3.38 and its 52-week low is $1.77. Its latest price of $2.12 on Nov 17, 2026 is 37.3% below the high.
What is RSSS's beta?
Research Solutions's 1-year beta against the S&P 500 is 0.40, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 43.1%.
Is the RSSS chart free?
Yes. Advanced Charting for RSSS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RSSS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors